Denali Therapeutics
DNLI
$13.74
Share price
11.80%
Change (1 day)
-29.10%
Change (1 year)
Categories
Operating Margin for Denali Therapeutics (DNLI)
Operating Margin as of April 2025 (TTM): -43.92%
According to Denali Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -43.92%. At the end of 2023 the company had an Operating Margin of -43.93%.
Operating Margin history for Denali Therapeutics from 2018 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -43.93% | -85.38% |
| 2022 | -300.54% | -49.77% |
| 2021 | -598.34% | -2890.99% |
| 2020 | 21.44% | -102.89% |
| 2019 | -742.05% | 2544.69% |
| 2018 | -28.06% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | -19.96% | -54.55% | Jersey |
 | -25.89% | -41.05% | 🇺🇸 USA |
 | -10,150.00% | 23,010.20% | 🇺🇸 USA |
 | -129.00% | 193.72% | 🇬🇧 UK |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.